Omeros receives $126M in sale of drug franchise to British eye care company By: Puget Sound Business Journal (Seattle) via Business Journals December 30, 2021 at 17:11 PM EST With royalties and a commercial milestone payment, Omeros says the deal is worth over $1 billion. Read More >> Related Stocks: Harbor Disruptive Innovation ETF